Michael Prummer
Overview
Explore the profile of Michael Prummer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
984
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Meyer D, Escher A, Riegler E, Keller D, Prummer M, Huber S, et al.
SLAS Technol
. 2025 Feb;
31:100258.
PMID: 39988115
High-throughput screening (HTS) is essential in preclinical research to identify new drug candidates for specific diseases. This process typically generates large amounts of data that require effective storage, management, and...
2.
Wegmann R, Bonilla X, Casanova R, Chevrier S, Coelho R, Esposito C, et al.
Nat Commun
. 2024 Oct;
15(1):9402.
PMID: 39477946
Deep single-cell multi-omic profiling offers a promising approach to understand and overcome drug resistance in relapsed or refractory (rr) acute myeloid leukemia (AML). Here, we combine single-cell ex vivo drug...
3.
Schmidli T, Sigg S, Keihani S, Bosshard L, Prummer M, Nowag A, et al.
World J Urol
. 2024 Sep;
42(1):554.
PMID: 39347837
Introduction: The American Association for the Surgery of Trauma (AAST) renal trauma grading leads to a variable management of patients with high-grade renal injuries. For a better prediction of the...
4.
Wirsching H, Felsberg J, Prummer M, Moisoiu V, Lourman R, Hertler C, et al.
Acta Neuropathol
. 2023 Aug;
146(4):647-649.
PMID: 37573572
No abstract available.
5.
Prummer M, Bertolini A, Bosshard L, Barkmann F, Yates J, Boeva V, et al.
NAR Genom Bioinform
. 2023 Jun;
5(2):lqad058.
PMID: 37332656
Identifying cell types based on expression profiles is a pillar of single cell analysis. Existing machine-learning methods identify predictive features from annotated training data, which are often not available in...
6.
Hausmann D, Todorski I, Pindur A, Weiland E, Benkert T, Bosshard L, et al.
Diagnostics (Basel)
. 2023 Feb;
13(4).
PMID: 36832095
This study investigated the image quality and choice of ultra-high b-value of two DWI breast-MRI research applications. The study cohort comprised 40 patients (20 malignant lesions). In addition to s-DWI...
7.
Hausmann D, Pindur A, Todorski I, Weiland E, Kuehn B, Zhou K, et al.
Acad Radiol
. 2022 Jul;
30(6):1129-1140.
PMID: 35871059
Rationale And Objectives: High-resolution T2-weighted magnetic resonance imaging (MRI) of the pelvis is the main technique used for diagnosing benign and malignant uterine diseases. However, the procedure may be time-consuming...
8.
Bertolini A, Prummer M, Tuncel M, Menzel U, Rosano-Gonzalez M, Kuipers J, et al.
PLoS Comput Biol
. 2022 Jun;
18(6):e1010097.
PMID: 35658001
Single-cell RNA sequencing (scRNA-seq) has emerged as a powerful technique to decipher tissue composition at the single-cell level and to inform on disease mechanisms, tumor heterogeneity, and the state of...
9.
Hausmann D, Perignon V, Grabherr R, Weiland E, Nickel M, Murer M, et al.
In Vivo
. 2021 Jun;
35(4):2217-2226.
PMID: 34182500
Background/aim: To determine whether a prototypical compressed-sensing volume-interpolated breath-hold (csVIBE) provides diagnostic value in detecting rectosigmoid infiltration in deep infiltrating endometriosis (DIE). Patients And Methods: csVIBE was employed in 151...
10.
Irmisch A, Bonilla X, Chevrier S, Lehmann K, Singer F, Toussaint N, et al.
Cancer Cell
. 2021 Jan;
39(3):288-293.
PMID: 33482122
The application and integration of molecular profiling technologies create novel opportunities for personalized medicine. Here, we introduce the Tumor Profiler Study, an observational trial combining a prospective diagnostic approach to...